Self-assembled nanoparticle and use thereof for anti- angiogenesis
US-2024033316-A1 · Feb 1, 2024 · US
US9011925B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9011925-B2 |
| Application number | US-201113282188-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 26, 2011 |
| Priority date | May 4, 2011 |
| Publication date | Apr 21, 2015 |
| Grant date | Apr 21, 2015 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A method for preparing polysaccharide nanocomposite particles is provided. The method comprises providing a first solution comprising an active component and a polysaccharide; adding a cross-linking agent to the first solution to provide a second solution; and allowing the second solution to conduct the reaction to form polysaccharide nanocomposite particles. The polysaccharide nanocomposite particles thus prepared show good coating ratio and enhanced applicability. Also provided is a method for inducing cancer cell apoptosis in a subject, comprising administrating to the subject an effective amount of the polysaccharide nanocomposite particles.
Opening claim text (preview).
What is claimed is: 1. A method for inducing cancer cell apoptosis in a subject as needed thereof, comprising administering to the subject an effective amount of a polysaccharide nanocomposite particle, wherein the polysaccharide nanocomposite particle comprises: a core, comprising an active component selected from the group consisting of a compound of formula (I) and a pharmaceutically acceptable salt or ester of the compound, a compound of formula (II) and a pharmaceutically acc…
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Related publications grouped by family.
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.